Crinetics Pharmaceuticals, Inc. (CRNX) › Shares OutstandingCrinetics Pharmaceuticals, Inc. (CRNX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2017: 1.55M2018: 24.1K2019: 24.26M2020: 33.00M2021: 47.60M2022: 53.88M2023: 68.17M2024: 92.93M2025: 95.58M95.58M2017Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202595.58M+2.9%202492.93M+36.3%202368.17M+26.5%202253.88M+13.2%202147.60M+44.2%202033.00M+36.0%201924.26M+100739.5%201824.1K-98.4%20171.55M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share